Treosulfan/fludarabine-based conditioning for allogeneic stem cell transplant in high-risk haematologic malignancies. A 5-years single-centre experience

被引：0
|
作者：
Baronciani, D. [1 ,3 ]
Depau, C. [1 ,3 ]
Targhetta, C. [1 ,3 ]
Pilo, F. [1 ,3 ]
Derudas, D. [1 ,3 ]
Culurgioni, F. [1 ,3 ]
Pani, M. [2 ]
Angelucci, E. [1 ,3 ]
机构：
[1] UO Ematol, Cagliari, Italy
[2] AO Brotzu, Cagliari, Italy
[3] CTMO PO Businco, Cagliari, Italy
来源：
BONE MARROW TRANSPLANTATION | 2011年 / 46卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S298 / S298
页数：1
相关论文
共 50 条
  • [41] Non-myeloablative stem cell transplantation for haematologic malignancies in patients 60 years or older, a single-centre study
    Guillaume, T
    Moreau, P
    Vigouroux, S
    Chevallier, P
    Mahé, B
    Delaunay, J
    Le Gouill, S
    Dubruille, V
    Gastine, T
    Milpied, N
    Harousseau, JL
    BONE MARROW TRANSPLANTATION, 2006, 37 : S197 - S198
  • [42] Reduced-toxicity conditioning with fludarabine and busulfan prior to allogeneic stem cell transplantation in multiple myeloma patients. A single-centre experience
    Grassi, A.
    Mico, C. M.
    Algarotti, A.
    Oldani, E.
    Rambaldi, A.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S427 - S427
  • [43] Outcomes of allogeneic stem cell transplantation (alloSCT) for myeloid malignancies in patients over 60 years of age: a single-centre experience
    Best, M.
    Lloyd, R.
    Hill, K.
    Jarvis, L.
    Main, S.
    Newman, J.
    McKeag, N.
    Richardson, D. D.
    Orchard, K.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S303 - S303
  • [44] REAL-WORLD, SINGLE-CENTRE OUTCOME DATA OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION UTILISING TREOSULFAN-BASED CONDITIONING REGIMENS
    Debes, Mohamed
    Lim, Yeong
    Seddon, Thomas
    Clarke, James
    Hawkins, Clare
    Smielewska, Anna
    Howard, Alex
    Grant, Julie
    Pervaiz, Sajid
    Iqbal, Shahid
    Toth, Arpad
    Saif, Muhammad
    BONE MARROW TRANSPLANTATION, 2024, 59 : 281 - 281
  • [45] Treosulfan–fludarabine–thiotepa-based conditioning treatment before allogeneic hematopoietic stem cell transplantation for pediatric patients with hematological malignancies
    Krzysztof Kalwak
    Monika Mielcarek
    Katharine Patrick
    Jan Styczynski
    Peter Bader
    Selim Corbacioglu
    Birgit Burkhardt
    Karl Walter Sykora
    Katarzyna Drabko
    Jolanta Gozdzik
    Franca Fagioli
    Johann Greil
    Bernd Gruhn
    Rita Beier
    Franco Locatelli
    Ingo Müller
    Paul Gerhardt Schlegel
    Petr Sedlacek
    Klaus Daniel Stachel
    Claudia Hemmelmann
    Ann-Kristin Möller
    Joachim Baumgart
    Ajay Vora
    Bone Marrow Transplantation, 2020, 55 : 1996 - 2007
  • [46] Treosulfan-fludarabine-thiotepa-based conditioning treatment before allogeneic hematopoietic stem cell transplantation for pediatric patients with hematological malignancies
    Kalwak, Krzysztof
    Mielcarek, Monika
    Patrick, Katharine
    Styczynski, Jan
    Bader, Peter
    Corbacioglu, Selim
    Burkhardt, Birgit
    Sykora, Karl Walter
    Drabko, Katarzyna
    Gozdzik, Jolanta
    Fagioli, Franca
    Greil, Johann
    Gruhn, Bernd
    Beier, Rita
    Locatelli, Franco
    Mueller, Ingo
    Schlegel, Paul Gerhardt
    Sedlacek, Petr
    Stachel, Klaus Daniel
    Hemmelmann, Claudia
    Moeller, Ann-Kristin
    Baumgart, Joachim
    Vora, Ajay
    BONE MARROW TRANSPLANTATION, 2020, 55 (10) : 1996 - 2007
  • [47] Outcome of allogeneic stem cell transplant in CML analysed according to the EBMT score-based risk groups - a single-centre experience
    Narayanan, P
    Sastry, P
    Mishra, B
    Mandhaniye, S
    Bhagwat, R
    Bakshi, A
    Biswas, G
    Parikh, P
    BONE MARROW TRANSPLANTATION, 2006, 37 : S231 - S231
  • [48] Conditioning with fludarabine and treosulfan compared to FLAMSA-RIC in allogeneic stem cell transplantation for myeloid malignancies: a retrospective single-center analysis
    Krischan Braitsch
    Alix Schwarz
    Katrin Koch
    Mara Hubbuch
    Helge Menzel
    Ulrich Keller
    Katharina S. Götze
    Florian Bassermann
    Peter Herhaus
    Mareike Verbeek
    Annals of Hematology, 2022, 101 : 1311 - 1319
  • [49] Outcomes of patients with high-risk acute myeloid leukaemia relapsed after allogeneic stem cell transplantation. Single-centre experience
    Steinerova, K.
    Koza, V.
    Jindra, P.
    Karas, M.
    Svoboda, T.
    Lysak, D.
    Vokurka, S.
    Vozobulova, V.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S116 - S116
  • [50] Conditioning with fludarabine and treosulfan compared to FLAMSA-RIC in allogeneic stem cell transplantation for myeloid malignancies: a retrospective single-center analysis
    Braitsch, Krischan
    Schwarz, Alix
    Koch, Katrin
    Hubbuch, Mara
    Menzel, Helge
    Keller, Ulrich
    Goetze, Katharina S.
    Bassermann, Florian
    Herhaus, Peter
    Verbeek, Mareike
    ANNALS OF HEMATOLOGY, 2022, 101 (06) : 1311 - 1319
12345